Details
With growing evidence demonstrating the superiority of whole-genome sequencing’s (WGS) utility for evaluating genetic diseases and economic feasibility, the momentum behind policy expansion, adoption and access will likely accelerate. Navigating towards a genome world requires a sequencing and informatics strategy to prepare for data management, scalability and the versality of applications (cardiology, neurology, pediatric rare disease, hereditary cancer).
Baylor Genetics leverages their AI and informatics automation workflow developed with Illumina technology to catalyze their operability for meeting a genome world.
Speaker:
Dr. Christine Eng, MD
Chief Medical Officer, Chief Quality Officer
Baylor Genetics
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- Mar 14, 2024
- Affiliation
- Baylor Genetics
- Presenter
- Dr. Christine Eng, MD
- Topic
- Complex disease genomics, Genetic & rare diseases